Skip to main navigation
Logo

Investors

SEC Filing Details

Document Details

Form
DRS
Filing Date
Sep 24, 2021
Document Date
Sep 24, 2021
Form Description
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Filing Group
Registration Statements
Company
AN2 Therapeutics, Inc
Issuer
AN2 THERAPEUTICS, INC.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

Shareholder Tools

Print Page
Email Alerts
RSS Feeds
Investor Contact
  • Investor Overview
  • News & Events
    • Press Releases
    • Events
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • Corporate Governance
    • Documents & Charters
    • Committee Composition
  • Financial Information
    • SEC Filings
  • IR Resources
    • Email Alerts
    • Contact IR
  • More
    • About Us
      • Mission
      • Leadership
      • Board of Directors
      • Founders
      • Partners
      • Expanded Access Policy
    • Technology
    • Pipeline
      • Epetraborole
      • NTM
    • Investors
      • Investor Overview
      • News & Events
        • Press Releases
        • Events
      • Stock Information
        • Stock Quote & Chart
        • Analyst Coverage
      • Corporate Governance
        • Documents & Charters
        • Committee Composition
      • Financial Information
        • SEC Filings
      • IR Resources
        • Email Alerts
        • Contact IR
    • Careers
      • Job Opportunities
      • Values
      • Benefits
    • Contact
    • Home
    • About Us
      • Mission
      • Leadership
      • Board of Directors
      • Founders
      • Partners
      • Expanded Access Policy
    • Technology
    • Pipeline
      • Epetraborole
      • NTM
    • Investors
      • Investor Overview
      • News & Events
        • Press Releases
        • Events
      • Stock Information
        • Stock Quote & Chart
        • Analyst Coverage
      • Corporate Governance
        • Documents & Charters
        • Committee Composition
      • Financial Information
        • SEC Filings
      • IR Resources
        • Email Alerts
        • Contact IR
    • Careers
      • Job Opportunities
      • Values
      • Benefits
    • Contact
    • Privacy Policy
    • Terms of Use
    Logo

    Location
    1800 El Camino Real, Suite D
    Menlo Park, CA 94027
    Phone: 650-331-9090

    General Information
    info@an2therapeutics.com

    Investor & Media Inquiries
    info@an2therapeutics.com

    Job Inquiries
    careers@an2therapeutics.com

    Business Development Contact
    partner@an2therapeutics.com

    linkedin

    • Privacy Policy
    • Terms of Use
    © 2023 AN2 Therapeutics All rights reserved.
    Website Design: Hane Chow, Inc.